Covid-19 roundup: US and Pfiz­er strike deal for 100M more dos­es; NIH and part­ners cut crit­i­cal­ly ill pa­tients out of blood thin­ner tri­al

The US gov­ern­ment has sealed a deal with Pfiz­er and BioN­Tech for 100 mil­lion ad­di­tion­al dos­es of their Covid-19 vac­cine, dou­bling the coun­try’s dose or­der.

Pfiz­er and BioN­Tech say they can de­liv­er the full 200 mil­lion dos­es by Ju­ly 31, 2021. The deal al­so in­cludes an op­tion for the US to pur­chase up to 400 mil­lion more down the road. The US is pay­ing an­oth­er $1.95 bil­lion for the ad­di­tion­al dos­es, at least 70 mil­lion of which should be de­liv­ered by June 30. The re­main­ing will be de­liv­ered by Ju­ly 31, ac­cord­ing to the com­pa­nies.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER